Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials (Q3842893): Difference between revisions
From MaRDI portal
Set profile property. |
Set OpenAlex properties. |
||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1080/03610929808832163 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2062627724 / rank | |||
Normal rank | |||
Revision as of 19:50, 19 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials |
scientific article |
Statements
Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials (English)
0 references
30 June 1999
0 references
conditional independence
0 references
exponential components
0 references
colorectal adjuvant clinical trials
0 references
